Actively Recruiting
The Suitability of Tience® for Treating Acne Scars
Led by Linio Biotech Oy · Updated on 2026-01-28
20
Participants Needed
1
Research Sites
87 weeks
Total Duration
On this page
Sponsors
L
Linio Biotech Oy
Lead Sponsor
C
Clinius Ltd
Collaborating Sponsor
AI-Summary
What this Trial Is About
This is an open-label, single-center, split-face, pseudo-randomized clinical trial designed to evaluate the efficacy and safety of a human-derived, cell-free adipose tissue derivative (Tience® ), for treating moderate to severe acne scars. Participants will receive three treatment sessions over a three-month period: on Day 0, Day 30, and Day 90. Treatment will be administered via injections to acne-scarred areas on one side of the face. The untreated side will be treated after the follow-up period. Outcomes will be evaluated over a twelve-month period using investigator clinical assessments, patient self-evaluation and VISIA skin analysis system to monitor changes in scar severity and overall skin quality.
CONDITIONS
Official Title
The Suitability of Tience® for Treating Acne Scars
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Healthy volunteers aged 18 to 40 years
- Have acne scars on their cheeks that are at least 3 years old
You will not qualify if you...
- Pregnancy or nursing
- Cancer or ongoing cancer treatment
- Active skin disease
- Fitzpatrick skin type 4 to 6
- Use of strong medications for severe acne (e.g., Isotretinoin)
- Active acne or Herpes
- Use of antihistamine medication unless it can be paused for 7 days during study visits
- Use of biological medications
- Tendency for excessive scar formation
- Tendency for urticaria (hives)
- Use of systemic medication affecting immunity
- Autoimmune disease
- Known blood clotting disorders (e.g., von Willebrand disease)
- Allergy to the study product or its ingredients
- Smoking
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Aava Kamppi Medical Centre
Helsinki, Finland, 001000
Actively Recruiting
Research Team
M
Minna Höst, Coordinator
CONTACT
L
Laura Bouchard, MD, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here